Douglas JT - Search Results

1

Barnett BG, Crews CJ, Douglas JT. Barnett BG, et al. Among authors: douglas jt. Biochim Biophys Acta. 2002 May 3;1575(1-3):1-14. doi: 10.1016/s0167-4781(02)00249-x. Biochim Biophys Acta. 2002. PMID: 12020813 Review.

2

Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells.

Barnett BG, Tillman BW, Curiel DT, Douglas JT. Barnett BG, et al. Among authors: douglas jt. Mol Ther. 2002 Sep;6(3):377-85. doi: 10.1006/mthe.2002.0670. Mol Ther. 2002. PMID: 12231174 Free article.

3

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.

Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. Kim M, et al. Among authors: douglas jt. Eur J Cancer. 2002 Sep;38(14):1917-26. doi: 10.1016/s0959-8049(02)00131-4. Eur J Cancer. 2002. PMID: 12204675

4

Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors.

Douglas JT, Curiel DT. Douglas JT, et al. Neuromuscul Disord. 1997 Jul;7(5):284-98. doi: 10.1016/s0960-8966(97)00053-9. Neuromuscul Disord. 1997. PMID: 9267842 Review.

5

Adenoviral vectors for gene therapy.

Douglas JT. Douglas JT. Mol Biotechnol. 2007 May;36(1):71-80. doi: 10.1007/s12033-007-0021-5. Mol Biotechnol. 2007. PMID: 17827541 Review.

6

Targeted gene delivery by tropism-modified adenoviral vectors.

Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Douglas JT, et al. Nat Biotechnol. 1996 Nov;14(11):1574-8. doi: 10.1038/nbt1196-1574. Nat Biotechnol. 1996. PMID: 9634824

7

A system for the propagation of adenoviral vectors with genetically modified receptor specificities.

Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, Curiel DT. Douglas JT, et al. Nat Biotechnol. 1999 May;17(5):470-5. doi: 10.1038/8647. Nat Biotechnol. 1999. PMID: 10331807

8

Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.

Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, Curiel DT. Tillman BW, et al. Among authors: douglas jt. Cancer Res. 2000 Oct 1;60(19):5456-63. Cancer Res. 2000. PMID: 11034088

9

Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.

Krasnykh V, Dmitriev I, Navarro JG, Belousova N, Kashentseva E, Xiang J, Douglas JT, Curiel DT. Krasnykh V, et al. Among authors: douglas jt. Cancer Res. 2000 Dec 15;60(24):6784-7. Cancer Res. 2000. PMID: 11156365 Review.

10

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Krasnykh VN, et al. Among authors: douglas jt. J Virol. 1996 Oct;70(10):6839-46. doi: 10.1128/JVI.70.10.6839-6846.1996. J Virol. 1996. PMID: 8794325 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page